logo

Cellect Biotechnology Ltd. (APOP)



Trade APOP now with
  Date
  Headline
5/11/2020 2:18:18 AM Cellect Reports Positive Data Showings Robust Engraftment Using ApoGraft Featured In Bone Marrow Transplantation
4/27/2020 8:08:02 AM Cellect Biotechnology Gets Official Communication Regarding Canadian Patent Application No. 2,866,358 For Apograft
1/8/2020 9:10:35 AM Cellect Biotechnology Prices $3 Mln Registered Direct Offering Of ADS
12/23/2019 7:04:10 AM Cellect Biotechnology Gets Approval To Initiate U.S. Trial To Evaluate Safety And Tolerability Of ApoGraft Technology
11/7/2019 8:13:13 AM Cellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price Requirement
8/13/2019 8:08:21 AM Cellect Biotechnology Q2 Net Loss $0.23 Mln Or $0.02/ADS Vs. Loss $1.64 Mln Or $0.26/ADS Last Year
5/21/2019 7:12:15 AM Cellect Biotechnology Q1 Net Loss $1.4 Mln Vs. Net Loss $1.03 Mln Last Year
5/16/2019 7:41:04 AM Cellect Biotechnology To Explore Strategic Alternatives To Maximize Shareholder Value
3/27/2019 8:03:58 AM Cellect Announces Positive Phase I/II Mid-Study Results Of ApoGraft Technology
3/11/2019 7:09:30 AM Cellect Announces Positive Preliminary Results From Collaboration With Cell2in On Improving Quality Of Stem Cells
2/8/2019 1:02:11 AM Cellect Announces Pricing Of Public Offering Of 1.889 Mln Units
1/28/2019 7:09:50 AM Cellect Biotechnology Concludes Scale-up Development And Manufacturing Of Clinical Grade FasL